Therapeutic role of miR-19a/b protection from influenza virus infection in patients with coronary heart disease
Description
Patients with pre-existing medical conditions are at a heightened risk of contracting severe acute respiratory syndrome (SARS), SARS-CoV-2, and influenza viruses, which can result in more severe disease progression and increased mortality rates
